E&G Advisors, LP Abb Vie Inc. Transaction History

E&G Advisors, LP

$357 Million
Q3 2024

A detailed history of E&G Advisors, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, E&G Advisors, LP holds 3,459 shares of ABBV stock, worth $696,988. This represents 0.19% of its overall portfolio holdings.

Number of Shares

3,459

Previous 3,459 -0.0%

Holding current value

$696,988

Previous $593,000 15.18%

% of portfolio

0.19%

Previous 0.18%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$159.82 - $182.1 $16,461 - $18,756	103 Added 3.07%	3,459 $629,000
Q3 2023 Oct 25, 2023	SELL	$133.59 - $154.65 $6,679 - $7,732	-50 Reduced 1.47%	3,356 $500,000
Q2 2023 Jul 21, 2023	BUY	$132.51 - $164.9 $13,251 - $16,490	100 Added 3.02%	3,406 $458,000
Q1 2023 Apr 17, 2023	SELL	$144.61 - $166.54 $31,814 - $36,638	-220 Reduced 6.24%	3,306 $526,000
Q3 2022 Oct 11, 2022	SELL	$134.21 - $153.93 $13,421 - $15,393	-100 Reduced 2.76%	3,526 $473,000
Q1 2022 Apr 12, 2022	SELL	$131.98 - $163.75 $13,197 - $16,375	-100 Reduced 2.68%	3,626 $588,000
Q4 2021 Jan 13, 2022	SELL	$107.43 - $135.93 $21,486 - $27,186	-200 Reduced 5.09%	3,726 $505,000
Q3 2021 Oct 20, 2021	BUY	$106.4 - $120.78 $417,726 - $474,182	3,926 New	3,926 $423,000
Q2 2021 Jul 12, 2021	SELL	$105.21 - $117.21 $392,012 - $436,724	-3,726 Closed	0 $442,000
Q1 2021 Apr 12, 2021	SELL	$102.3 - $112.62 $3,785 - $4,166	-37 Reduced 0.98%	3,726 $403,000
Q4 2020 Jan 26, 2021	BUY	$80.49 - $108.67 $4,024 - $5,433	50 Added 1.35%	3,763 $403,000
Q3 2020 Oct 13, 2020	SELL	$85.91 - $100.83 $46,906 - $55,053	-546 Reduced 12.82%	3,713 $325,000
Q2 2020 Jul 07, 2020	BUY	$73.37 - $98.18 $19,002 - $25,428	259 Added 6.48%	4,259 $418,000
Q2 2019 Jul 12, 2019	BUY	$65.7 - $83.98 $16,753 - $21,414	255 Added 6.81%	4,000 $291,000
Q1 2019 Apr 18, 2019	SELL	$77.14 - $90.79 $112,238 - $132,099	-1,455 Reduced 27.98%	3,745 $302,000
Q3 2018 Oct 10, 2018	BUY	$88.91 - $98.84 $462,332 - $513,968	5,200 New	5,200 $492,000
Q4 2017 Jan 16, 2018	SELL	$89.56 - $98.21 $349,284 - $383,019	-3,900 Closed	0 $0
Q3 2017 Oct 20, 2017	BUY	$69.85 - $89.22 $272,415 - $347,958	3,900	3,900 $347,000

Others Institutions Holding ABBV

# of Institutions

3,760

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $356B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E&G Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on E&G Advisors, LP with notifications on news.

Account